Gandeeva Therapeutics reposted this
CEO, Gandeeva Therapeutics and Gobind Khorana Canada Excellence Research Chair, Precision Cancer Drug Design, University of British Columbia
One of the highlights of the Bloom Burton & Co. Healthcare Investor Conference last week was the chance to meet up with some of the best in the west! It was a real pleasure to catch up with Life Sciences BC and (left to right) Ali Ardakani, David Frost, Wendy Hurlburt, Lana Janes, Ph.D. at #BBHIC2024.
On July 25 at 3:00 pm, Gandeeva Therapeutics Founder and CEO Sriram Subramaniam will present his talk, Leveraging Cryo-EM & AI for Discovery of Molecular Glues, at the Induced Proximity-Based Drug Discovery summit in Boston, MA. https://lnkd.in/gSg66RUA #cryoEM #molecularglues
Gandeeva Therapeutics is proud to partner with PROGENITER, a collaboration between researchers at The University of British Columbia, Simon Fraser University, and global pharmaceutical and biotechnology companies in Canada to scale up Canadian pandemic preparedness, therapeutic discovery, and biomanufacturing capacity. Congratulations to the PROGENITER team!
Today, Randeep Sarai and Benoit-Antoine Bacon celebrated $140M in Canadian Science funding for projects that will advance the development of life-saving medicines as part of Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) led by UBC. The funding supports four multidisciplinary research projects through CIEBH, a UBC-led alliance of more than 50 academic, industry, not-for-profit and health system partners that have come together to make Canada a leader in advanced immune-based therapeutics like RNA vaccines, antibody treatments and cell therapies. Collectively, the projects aim to establish an end-to-end drug development pipeline that will enable Canada to mount a rapid 100-day response to emerging pandemic threats and other health challenges. Read more: https://bit.ly/3X5C3M4 #cdnpoli #cdned
Thank you to The University of British Columbia's President and Vice-Chancellor, Benoit-Antoine Bacon, for highlighting Gandeeva Therapeutics and our CEO, Sriram Subramaniam, at this week's presentation to the Greater Vancouver Board of Trade. We’re proud of our #UBC roots, and to be part of the BC life sciences and #biotech community! #LSBC
It’s Friday, the science is good, and the #StanleyCup playoffs are in full swing. Gandeeva Therapeutics and the Vancouver Canucks can always count on Charles Leung, Ph.D., PMP, for enthusiasm and support! #AllTogether #Canucks
Nice to see Sriram Subramaniam conquer the #VanSunRun this sunny morning, and in Gandeeva blue! This annual Vancouver race for charity was established by Dr. Jack Taunton, the researcher/physician co-founder of the Allan McGavin Sports Medicine Centre and founder of #SportsMedBC. This year, more than 45,000 people registered to participate. Gandeeva Therapeutics staff are an active bunch, with runners, climbers, soccer players, tennis buffs, yogis, and softball players in our mix, and we love to see our CEO leading the way! #WorkHardPlayHard
This afternoon, Sriram Subramaniam presented at the Bloom Burton & Co. Healthcare Investor Conference. Gandeeva Therapeutics is grateful for the opportunity to tell our story at #BBHIC2024!
Gandeeva Therapeutics will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 17 at 2:00 p.m. ET. #BloomBurton #BBHIC2024 https://ow.ly/n4S450R72uC
